A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer

MLA

Zhenyu Pan, et al. “A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-Small-Cell Lung Cancer.” Frontiers in Oncology, vol. 9, Aug. 2019. EBSCOhost, https://doi.org/10.3389/fonc.2019.00838.

APA

Zhenyu Pan, Guozi Yang, Jiuwei Cui, Wei Li, Yu Li, Pengxiang Gao, Tongchao Jiang, Yanan Sun, Lihua Dong, Yuanyuan Song, & Gang Zhao. (2019). A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.00838

Chicago

Zhenyu Pan, Guozi Yang, Jiuwei Cui, Wei Li, Yu Li, Pengxiang Gao, Tongchao Jiang, et al. 2019. “A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-Small-Cell Lung Cancer.” Frontiers in Oncology 9 (August). doi:10.3389/fonc.2019.00838.